The effects of calcitriol therapy on serum interleukin-1, interleukin-6 and tumour necrosis factor-alpha concentrations in post-menopausal patients with osteoporosis (Q45179662)

From Wikidata

Jump to navigation Jump to search

scientific article published in November 2004

Language	Label	Description	Also known as
English	The effects of calcitriol therapy on serum interleukin-1, interleukin-6 and tumour necrosis factor-alpha concentrations in post-menopausal patients with osteoporosis	scientific article published in November 2004

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

The effects of calcitriol therapy on serum interleukin-1, interleukin-6 and tumour necrosis factor-alpha concentrations in post-menopausal patients with osteoporosis (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

0 references

0 references

0 references

author name string

A Inanir

1

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

K Ozoran

2

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

H Tutkak

3

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

B Mermerci

4

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

publication date

1 November 2004

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Journal of International Medical Research

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

32

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

570-582

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Treatment of osteoporosis: role of bone-forming agents

1 reference

https://api.crossref.org/works/10.1177%2F147323000403200602

21 January 2018

An update on the diagnosis and assessment of osteoporosis with densitometry. Committee of Scientific Advisors, International Osteoporosis Foundation

1 reference

https://api.crossref.org/works/10.1177%2F147323000403200602

21 January 2018

Periosteal bone formation--a neglected determinant of bone strength

1 reference

https://api.crossref.org/works/10.1177%2F147323000403200602

21 January 2018

Role of the vitamin D-endocrine system in the pathophysiology of postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1177%2F147323000403200602

21 January 2018

Vitamin D deficiency and osteoporosis: the role of vitamin D deficiency and treatment with vitamin D and analogues in the prevention of osteoporosis-related fractures

1 reference

https://api.crossref.org/works/10.1177%2F147323000403200602

21 January 2018

The role of calcitriol in the treatment of osteoporosis

1 reference

https://api.crossref.org/works/10.1177%2F147323000403200602

21 January 2018

Estrogen deficiency induces bone loss by increasing T cell proliferation and lifespan through IFN-gamma-induced class II transactivator.

1 reference

https://api.crossref.org/works/10.1177%2F147323000403200602

21 January 2018

Mathematical model predicts a critical role for osteoclast autocrine regulation in the control of bone remodeling

1 reference

https://api.crossref.org/works/10.1177%2F147323000403200602

21 January 2018

Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice

1 reference

https://api.crossref.org/works/10.1177%2F147323000403200602

21 January 2018

Cytokines and bone loss in a 5-year longitudinal study--hormone replacement therapy suppresses serum soluble interleukin-6 receptor and increases interleukin-1-receptor antagonist: the Danish Osteoporosis Prevention Study

1 reference

https://api.crossref.org/works/10.1177%2F147323000403200602

21 January 2018

Clinical consequences of vertebral fractures

1 reference

https://api.crossref.org/works/10.1177%2F147323000403200602

21 January 2018

Action of 1,25-dihydroxyvitamin D3 on calcium balance and bone turnover and its effect on vertebral fracture rate

1 reference

https://api.crossref.org/works/10.1177%2F147323000403200602

21 January 2018

Calcium, vitamin D and vitamin K in the prevention of fractures due to osteoporosis

1 reference

https://api.crossref.org/works/10.1177%2F147323000403200602

21 January 2018

Calcitriol treatment is not effective in postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1177%2F147323000403200602

21 January 2018

Withdrawal of hormone replacement therapy is associated with significant vertebral bone loss in postmenopausal women

1 reference

https://api.crossref.org/works/10.1177%2F147323000403200602

21 January 2018

Anabolic effect of long-term estrogen replacement on bone collagen in elderly postmenopausal women with osteoporosis

1 reference

https://api.crossref.org/works/10.1177%2F147323000403200602

21 January 2018

Determinants of peak bone mass and mechanisms of bone loss

1 reference

https://api.crossref.org/works/10.1177%2F147323000403200602

21 January 2018

Immunologic aspects of osteoporosis

1 reference

https://api.crossref.org/works/10.1177%2F147323000403200602

21 January 2018

Interleukin-11: a new cytokine critical for osteoclast development

1 reference

https://api.crossref.org/works/10.1177%2F147323000403200602

21 January 2018

Alcohol, cytokines, and estrogen in the control of bone remodeling

1 reference

https://api.crossref.org/works/10.1177%2F147323000403200602

21 January 2018

Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1177%2F147323000403200602

21 January 2018

Rationale for active vitamin D analog therapy in senile osteoporosis.

1 reference

https://api.crossref.org/works/10.1177%2F147323000403200602

21 January 2018

Inhibition of interleukin-1 production by 1,25-dihydroxyvitamin D3

1 reference

https://api.crossref.org/works/10.1177%2F147323000403200602

21 January 2018

Identifiers

10.1177/147323000403200602

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

release_tcpqzkp4irhxlbqjhwwxsycxmu

1 reference

https://api.fatcat.wiki/v0/release/tcpqzkp4irhxlbqjhwwxsycxmu

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45179662&oldid=2107822933"